DK0656014T3 - Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition - Google Patents

Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition

Info

Publication number
DK0656014T3
DK0656014T3 DK94911348T DK94911348T DK0656014T3 DK 0656014 T3 DK0656014 T3 DK 0656014T3 DK 94911348 T DK94911348 T DK 94911348T DK 94911348 T DK94911348 T DK 94911348T DK 0656014 T3 DK0656014 T3 DK 0656014T3
Authority
DK
Denmark
Prior art keywords
protein
pharmaceutical composition
many group
reagent kit
immunity
Prior art date
Application number
DK94911348T
Other languages
Danish (da)
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Application granted granted Critical
Publication of DK0656014T3 publication Critical patent/DK0656014T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94911348T 1993-03-19 1994-03-21 Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition DK0656014T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK0656014T3 true DK0656014T3 (da) 2003-08-11

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911348T DK0656014T3 (da) 1993-03-19 1994-03-21 Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition

Country Status (17)

Country Link
US (1) US5869064A (pt)
EP (1) EP0656014B1 (pt)
JP (1) JP3976334B2 (pt)
KR (1) KR100331358B1 (pt)
CN (1) CN1046291C (pt)
AT (1) ATE240351T1 (pt)
CA (1) CA2158658A1 (pt)
DE (1) DE69432658T2 (pt)
DK (1) DK0656014T3 (pt)
ES (1) ES2194024T3 (pt)
HU (1) HU217582B (pt)
NZ (1) NZ263275A (pt)
PT (1) PT656014E (pt)
SG (1) SG47049A1 (pt)
SI (1) SI0656014T1 (pt)
WO (1) WO1994021685A1 (pt)
ZA (1) ZA941958B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
ATE347600T1 (de) 1998-02-20 2006-12-15 Id Biomedical Corp Gruppe b-streptococcus antigene
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
ES2281977T3 (es) * 1998-12-22 2007-10-01 Microscience Limited Proteinas de estreptococo del grupo b y su utilizacion.
AU758722B2 (en) * 1998-12-22 2003-03-27 Microscience Limited Outer surface proteins, their genes, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
PL205041B1 (pl) * 1998-12-23 2010-03-31 Id Biomedical Corp Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
JP3934605B2 (ja) * 2001-05-31 2007-06-20 扶桑薬品工業株式会社 感染症原因微生物の検出および同定のための改良された方法
CA2447775A1 (en) * 2001-05-31 2002-12-19 Fuso Pharmaceutical Industries, Ltd. Process for evaluating phagocytotic function and use thereof
EP1472353B1 (en) * 2002-02-11 2012-02-01 ID Biomedical Corporation Group b streptococcus antigen
CA2597170A1 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biological S North America Pharmaceutical compositions
PT2144924T (pt) * 2007-04-16 2016-08-17 Minervax Aps Vacina de proteína de fusão
CA3001433A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
WO2017114655A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
EP3638301A1 (en) 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
BR112022008761A2 (pt) 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein
EP4748391A1 (en) 2024-11-20 2026-05-27 MinervaX ApS N-terminal region of a group b streptococcus surface protein as a carrier for the capsular polysaccharide
EP4748392A1 (en) 2024-11-20 2026-05-27 MinervaX ApS Vaccine formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
JPH06506114A (ja) * 1991-03-29 1994-07-14 ファウルマン，　エルビン 新規な遺伝子及びＩｇＡ結合蛋白質の製造方法

Also Published As

Publication number Publication date
JPH09500092A (ja) 1997-01-07
ES2194024T3 (es) 2003-11-16
KR960701096A (ko) 1996-02-24
HK1008825A1 (en) 1999-05-21
DE69432658D1 (de) 2003-06-18
CN1046291C (zh) 1999-11-10
KR100331358B1 (ko) 2002-08-13
SI0656014T1 (en) 2003-12-31
CA2158658A1 (en) 1994-09-29
EP0656014A1 (en) 1995-06-07
AU6389194A (en) 1994-10-11
ATE240351T1 (de) 2003-05-15
HUT72841A (en) 1996-05-28
CN1119442A (zh) 1996-03-27
EP0656014B1 (en) 2003-05-14
AU681130B2 (en) 1997-08-21
PT656014E (pt) 2003-09-30
WO1994021685A1 (en) 1994-09-29
HU9501993D0 (en) 1995-08-28
SG47049A1 (en) 1998-03-20
DE69432658T2 (de) 2004-04-08
JP3976334B2 (ja) 2007-09-19
ZA941958B (en) 1995-01-27
NZ263275A (en) 1997-07-27
US5869064A (en) 1999-02-09
HU217582B (hu) 2000-02-28

Similar Documents

Publication Publication Date Title
HUT72841A (en) Protein rib, a cell surface protein that confers immunity to strains of the group b streptococcus; process for purification of the protein; reagent kit, and pharmaceutical composition
DK1398379T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
ATE323721T1 (de) Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
CA2123579A1 (en) Recombinant multivalent m protein vaccine
PT726955E (pt) Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
EP1589109A3 (en) VMP-like sequences of pathogenic borrelia
WO2001098460A3 (en) Fusion proteins of mycobacterium tuberculosis
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
NO944245D0 (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
BR9812791A (pt) Sequências de ácido nucléico associadas à virulência e seu uso
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
SE9804491D0 (sv) Novel fibronectin-binding protein
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
DK381787D0 (da) Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis
DE60031106D1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments